Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01097759
Other study ID # 58061302393
Secondary ID
Status Completed
Phase N/A
First received April 1, 2010
Last updated April 1, 2010
Start date January 2006
Est. completion date July 2008

Study information

Verified date January 2006
Source Kuwait Oil Company Ahmadi Hospital
Contact n/a
Is FDA regulated No
Health authority Kuwait: Ministry of Health
Study type Observational

Clinical Trial Summary

This study was designed to compare the outcome of LigaSure hemorrhoidectomy and stapled hemorrhoidopexy for prolapsed hemorrhoids.


Description:

The study was designed as a single-blind, prospective, randomized controlled trial and was approved by the Ethics Committee of Ahmadi Hospital, Kuwait. Patients were randomly assigned to undergo either hemorrhoidectomy with the LigaSure device or stapled hemorrhoidopexy. Patients were blinded as to the type of procedure perform. Candidates for the study were consecutive patients with symptomatic grade III or IV hemorrhoids admitted to the Ahmadi Hospital (secondary care hospital), Kuwait, from January 2006 through July 2007.


Recruitment information / eligibility

Status Completed
Enrollment 115
Est. completion date July 2008
Est. primary completion date July 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult (above 18 years)

- With prolapsed hemorrhoids (grades III or IV)

Exclusion Criteria:

- Complicated hemorrhoid

- Coexisting perianal disease

- Previous perianal surgery

- Unfit for general anesthesia

- Pregnancy

- History of bleeding tendency

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Surgery
Hemorrhoidectomy using the LigaSure sealing device or hemorrhoidopexy using the stapler

Locations

Country Name City State
Kuwait Ahmadi Hospital Ahmadi

Sponsors (2)

Lead Sponsor Collaborator
Kuwait Oil Company Ahmadi Hospital Netherlands: Ministry of Health, Welfare and Sports

Country where clinical trial is conducted

Kuwait, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of postoperative pain Postoperative pain was assessed using the visual analogue scale (VAS) 12 months No
Secondary Assessment of postoperative complications Postoperative complications and their management were compared between both groups during the followup visits for 12 months 12 months Yes